Hostname: page-component-76fb5796d-2lccl Total loading time: 0 Render date: 2024-04-27T19:31:04.940Z Has data issue: false hasContentIssue false
  • English
  • Français

Recent Progress: Progress in Understanding Huntington’s Chorea

Published online by Cambridge University Press:  18 September 2015

André Barbeau
André Barbeau*
Affiliation:
Institut De Recherches Cliniques De Montréal, 110 avenue des Pins oues, Montréal Qué, Canada H2W 1R7
*
Reprint requests to Dr. Andre Barbeau at the Institute
Rights & Permissions [Opens in a new window]

Summary:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The present paper analyses the new data accumulated since 1972 concerning the etiology and pathogenesis of Huntington’s chorea. Particular attention is paid to the respective roles of the dopaminergic and GABA-ergic systems.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 2 , Issue 2 , May 1975 , pp. 81 - 85
Copyright
Copyright © Canadian Neurological Sciences Federation 1975

References

REFERENCES

Aminoff, M.J.Trenchard, A.Turner, P.Wood, W.G. and Hills, M. (1974). Plasma uptake of dopamine and 5-hydroxytryptamine and plasma catecholamine levels in patients with Huntington’s chorea. Lancet 2, 1115–1116.CrossRefGoogle ScholarPubMed
ANONYMOUS EDITORIAL (1974). Dopamine and G.A.B.A. in Huntington’s chorea. Lancet 2, 1122–1123.Google Scholar
ANONYMOUS EDITORIAL (1974). G.A.D. and G.A.B.A., Lancet 1, 298–300.Google Scholar
Barbeau, A. (1973). G.A.B.A. and Huntington’s chorea. Lancet 1, 1499–1500.CrossRefGoogle Scholar
Barbeau, A. (1975). Dopamine and Huntington’s chorea. Lancet, in press.CrossRefGoogle Scholar
Barbeau, A.Campanella, G.Butterworth, R.F. and Yamada, K. (1975). Uptake and efflux of 14C-dopamine in platelets: Evidence for a generalized defect in Parkinson’s disease. Neurology 25, 1–9.CrossRefGoogle ScholarPubMed
Barbeau, A.Chase, T.N. and Paulson, G.W. (Eds) (1973). Huntington’s chorea 1872–1972. Advances in Neurology, Vol 1, Raven Press, New York, pp. 1–826.Google Scholar
Bernheimer, H.Birkmayer, W.Hornykiewicz, O.Jellinger, K. and Seitelberger, F. (1973). Brain dopamine and the syndromes of Parkinson and Huntington — Clinical, morphological and neurochemical correlation. Journal of Neurological Sciences 20, 415–455.CrossRefGoogle Scholar
Bird, E.D. and Iversen, L.L. (1974). Huntington’s chorea — Post-mortem measurement of glutamic acid decarboxylase, choline acetyl transferase and dopamine in basal ganglia. Brain 97, 457–472.CrossRefGoogle Scholar
Bowen, D.M.White, P. and Davison, A.N. (1974). Glutamic acid (GAD) and dehydroxyphenylalanine (DOPAD) decarboxylase activities in senile dementia. Proceedings 7th International Congress of Neuropathology, Akadémiai Kiado, Budapest, p. 41.Google Scholar
Bruyn, G.W.Baro, F. and Myrianthopoulos, N.T. (1974). A centennial bibliography of Huntington’s chorea. Leuven University Press, Louvain, pp. 1–314.Google Scholar
Butterworth, R.F.Poignant, J.C. and Barbeau, A. (1975). Apomorphine and Piribedil in rats: Biochemical and pharmacologic studies. In: Advances in Neurology, Vol. 9, Raven Press, New York, pp. 307–326.Google Scholar
Carman, J.S.Shoulson, I. and Chase, T.N. (1974). Huntington’s chorea treated with lithium carbonate. Lancet, 1, 811.CrossRefGoogle ScholarPubMed
Cools, A.R. and Van Rossum, M.J. (1970). Caudal dopamine and stereotyped behaviour in cats. Archives Internationales de Pharmacodynamic et de thérapie 187, 163–173.Google Scholar
Costall, B. and Naylor, R.J. (1974). The importance of the ascending dopaminergic systems to the extrapyramidal and mesolimbic brain areas for the cataleptic action of the neuroleptic and cholinergic agents. Neuropharmacology 13, 353–364.CrossRefGoogle Scholar
Courville, C.B.Nusbaum, R.E. and Butt, E.M. (1963). Changes in trace metals in brains of Huntington’s chorea. Archives of Neurology (Chicago) 8: 481–489.Google Scholar
Crow, T.J. (1974). Huntington’s chorea and GABA. Nature 252, 634–635.CrossRefGoogle Scholar
Curzon, G. and Wald, I. (1963). A quantitative Simola test and its application to the investigation of extrapyramidal syndromes. Clinical Chimica Acta 8, 898–901.CrossRefGoogle Scholar
Dalen, P. (1973). Lithium carbonate in Huntington’s chorea. Lancet 1, 107.Google Scholar
Ehringer, H. and Hornykiewicz, O. (1960). Verteilung von noradrenalin und dopamin (3-hydroxytyramin) im gehirn des menschen und ihr verhalten bei erkrankungen des extrapyramidalen system. Klinische Wochenschrift 38, 1236–1237.CrossRefGoogle Scholar
Fahn, S. and Cote, L.J. (1968). Regional distribution of GAMMA-aminobutyric acid (GABA) in brain of the rhesus monkey. Journal of Neurochemistry 15, 209–213.CrossRefGoogle ScholarPubMed
Fisher, R.Norris, J.W. and Gilka, L. (1974). G.A.B.A. in Huntington’s chorea. Lancet 1, 506.CrossRefGoogle ScholarPubMed
Iqbal, K.Tellez-Nagel, I. and Grundke-Iqbal, I. (1974). Protein abnormalities in Huntington’s chorea. Brain Research 76, 178–184.CrossRefGoogle ScholarPubMed
Izumi, K.Donaldson, J.Minnich, J.L. and Barbeau, A. (1973). Ouabaininduced seizures in rats: suppressive effects of tauraine and γ-aminobutyric acid. Canadian Journal of Physiology and Pharmacology 51, 885–889.CrossRefGoogle ScholarPubMed
Klawans, H.L. (1970) A pharmacologic analysis of Huntington’s chorea. European Neurology 4, 148–163.CrossRefGoogle ScholarPubMed
Klawans, H.L.Paulson, G.W.Ringel, S.P. and Barbeau, A. (1972). L-DOPA in the detection of presymptomatic Huntington’s chorea. New England Journal of Medicine 286, 1332–1334.CrossRefGoogle ScholarPubMed
Laaksonen, H.Rinne, U.K.Riekkinen, P. and Sonninen, V. (1974). Brain glutamic acid decarboxylase activity in Parkinson’s disease. Proceedings 7th International Congress of Neuropathology, Akadémiai Kiado, Budapest, p. 172.Google Scholar
Leonard, D.P.Kidson, M.A.Shannon, M.A. and Brown, J. (1974). Double-blind trial of lithium carbonatè and haloperidal in Huntingtons Chorea. Lancet, 7890 (2), 1208–9.CrossRefGoogle Scholar
Lloyd, K.G. and Hornykiewicz, O. (1973). L-glutamic acid decarboxylase in Parkinson’s disease. Effect of L-DOPA therapy. Nature, London 243, 521–523.CrossRefGoogle ScholarPubMed
Mattson, B. (1974). Clinical, genetic and pharmacological studies in Huntington’s chorea. Umea University Medical Dissertation 7, 1–120.Google Scholar
Mattson, B. and Boman, K. (1974). Buronil in Huntington’s chorea. Lancet 2, 1323.CrossRefGoogle Scholar
McGeer, P.L.McGeer, E.G. and Fibiger, H.C. (1973). Cholineacetylase and glutamic acid decarboxylase in Huntington’s chorea. A preliminary study. Neurology, Minn. 23, 912–917.CrossRefGoogle Scholar
McGeer, P.L.McGeer, E.G.Fibiger, H.C. and Wickson, V. (1971). Neostriatal choline acetylase and cholinesterase following selective brain lesions. Brain Research 35, 308–314.CrossRefGoogle ScholarPubMed
McLellan, D.L.Chalmers, R.J. and Johnson, R.H. (1974). A doubleblind trial of tetrabenazine, thiopropazate, and placebo in patients with chorea. Lancet 1, 104–107.CrossRefGoogle ScholarPubMed
Olivier, A.Parent, A.Simard, H. and Poirier, L.J. (1970). Cholinesterasic striato-pallidal and striatal nigral efferents in the cat and monkey. Brain Research 18, 273–282.CrossRefGoogle Scholar
Orzeck, A. and Barbeau, A. (1970). Interrelationships among dopamine, serotonin and acetylcholine, L-DOPA and Parkinsonism, Davis, F.A.Philadelphia, pp. 88–94.Google Scholar
Perry, T.L. and Hansen, S. (1973). Sustained drug-induced elevation of brain GABA in the rat. Journal of Neurochemistry 21, 1167–1175.CrossRefGoogle ScholarPubMed
Perry, T.L.Hansen, S. and Kloster, M. (1973). Huntington’s chorea: Deficiency of γ-aminobutyric acid in brain. New England Journal of Medicine 288, 337–342.CrossRefGoogle ScholarPubMed
Perry, T.L.Hansen, S. and Urquhart, N. (1974). G.A.B.A. in Huntington’s chorea. Lancet 1, 995–996.CrossRefGoogle ScholarPubMed
Podolsky, S. and Leopold, N.A. (1973). Biogenic amines in the hypothalamus: Effect of L-DOPA on human growth hormone levels in patients with Huntington’s chorea, Pick’s disease, and paralysis agitans. Progress in Brain Research 39, 225–235.CrossRefGoogle Scholar
Sourkes, T.L.Pivnicki, D.Brown, W.T. and Wiseman-Distler, M.H. (1964). Studies on amine metabolism in Huntington’s chorea. Canadian Medical Association Journal 90, 487–500.Google Scholar
Stahl, W.L. and Swanson, P.D. (1974). Biochemical abnormalities in Huntington’s chorea brain. Neurology 24, 813–819.CrossRefGoogle Scholar
Van Wolferen, W.J.A.Bruyn, G.W. and Teepen, J.L.J.M. (1974). Pathogenesis of Huntington’s chorea, Pick’s disease, and paralysis agitans. Lancet 1, 1112.CrossRefGoogle ScholarPubMed
Wood, J.D. and Peesker, S.J. (1973). Increasing GABA levels in experimental animals. Journal of Neurochemistry 20, 379–387.CrossRefGoogle Scholar